154 related articles for article (PubMed ID: 12190618)
1. Autophosphorylation kinetics of protein kinases.
Wang ZX; Wu JW
Biochem J; 2002 Dec; 368(Pt 3):947-52. PubMed ID: 12190618
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the catalytic mechanism of the p21-activated protein kinase PAK2.
Wu H; Zheng Y; Wang ZX
Biochemistry; 2003 Feb; 42(4):1129-39. PubMed ID: 12549935
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the kinetic properties of the lipid- and protein-kinase activities of the p110alpha and p110beta catalytic subunits of class-Ia phosphoinositide 3-kinases.
Beeton CA; Chance EM; Foukas LC; Shepherd PR
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):353-9. PubMed ID: 10947948
[TBL] [Abstract][Full Text] [Related]
4. A dimeric kinase assembly underlying autophosphorylation in the p21 activated kinases.
Pirruccello M; Sondermann H; Pelton JG; Pellicena P; Hoelz A; Chernoff J; Wemmer DE; Kuriyan J
J Mol Biol; 2006 Aug; 361(2):312-26. PubMed ID: 16837009
[TBL] [Abstract][Full Text] [Related]
5. [Mechanism of action of cAMP-dependent protein kinase. V. Free energy spectra].
Kochetkov SN; Abduragimov AR; Gabibov AG; Severin ES
Mol Biol (Mosk); 1985; 19(6):1562-8. PubMed ID: 4079933
[TBL] [Abstract][Full Text] [Related]
6. Pyruvate dehydrogenase kinase isoform 2 activity stimulated by speeding up the rate of dissociation of ADP.
Bao H; Kasten SA; Yan X; Hiromasa Y; Roche TE
Biochemistry; 2004 Oct; 43(42):13442-51. PubMed ID: 15491151
[TBL] [Abstract][Full Text] [Related]
7. A mechanism-based cross-linker for the identification of kinase-substrate pairs.
Maly DJ; Allen JA; Shokat KM
J Am Chem Soc; 2004 Aug; 126(30):9160-1. PubMed ID: 15281787
[TBL] [Abstract][Full Text] [Related]
8. Pyruvate dehydrogenase kinase isoform 2 activity limited and further inhibited by slowing down the rate of dissociation of ADP.
Bao H; Kasten SA; Yan X; Roche TE
Biochemistry; 2004 Oct; 43(42):13432-41. PubMed ID: 15491150
[TBL] [Abstract][Full Text] [Related]
9. Discovery and characterization of a substrate selective p38alpha inhibitor.
Davidson W; Frego L; Peet GW; Kroe RR; Labadia ME; Lukas SM; Snow RJ; Jakes S; Grygon CA; Pargellis C; Werneburg BG
Biochemistry; 2004 Sep; 43(37):11658-71. PubMed ID: 15362850
[TBL] [Abstract][Full Text] [Related]
10. A kinetic test characterizes kinase intramolecular and intermolecular autophosphorylation mechanisms.
Dodson CA; Yeoh S; Haq T; Bayliss R
Sci Signal; 2013 Jul; 6(282):ra54. PubMed ID: 23821772
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of peanut serine/threonine/tyrosine protein kinase: molecular docking and inhibition kinetics with tyrosine kinase inhibitors.
Rudrabhatla P; Rajasekharan R
Biochemistry; 2004 Sep; 43(38):12123-32. PubMed ID: 15379551
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the structure-activity relationship of four herpesviral UL97 subfamily protein kinases reveals partial but not full functional conservation.
Romaker D; Schregel V; Maurer K; Auerochs S; Marzi A; Sticht H; Marschall M
J Med Chem; 2006 Nov; 49(24):7044-53. PubMed ID: 17125257
[TBL] [Abstract][Full Text] [Related]
13. Role of the PH domain in regulating in vitro autophosphorylation events required for reconstitution of PDK1 catalytic activity.
Gao X; Harris TK
Bioorg Chem; 2006 Aug; 34(4):200-23. PubMed ID: 16780920
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase inhibitors: insights into drug design from structure.
Noble ME; Endicott JA; Johnson LN
Science; 2004 Mar; 303(5665):1800-5. PubMed ID: 15031492
[TBL] [Abstract][Full Text] [Related]
15. Activation of an S6/H4 kinase (PAK 65) from human placenta by intramolecular and intermolecular autophosphorylation.
Benner GE; Dennis PB; Masaracchia RA
J Biol Chem; 1995 Sep; 270(36):21121-8. PubMed ID: 7673144
[TBL] [Abstract][Full Text] [Related]
16. Bypassing a kinase activity with an ATP-competitive drug.
Papa FR; Zhang C; Shokat K; Walter P
Science; 2003 Nov; 302(5650):1533-7. PubMed ID: 14564015
[TBL] [Abstract][Full Text] [Related]
17. Development and implementation of three mitogen-activated protein kinase (MAPK) signaling pathway imaging assays to provide MAPK module selectivity profiling for kinase inhibitors: MK2-EGFP translocation, c-Jun, and ERK activation.
Nickischer D; Laethem C; Trask OJ; Williams RG; Kandasamy R; Johnston PA; Johnston PA
Methods Enzymol; 2006; 414():389-418. PubMed ID: 17110204
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the cloned full-length and a truncated human target of rapamycin: activity, specificity, and enzyme inhibition as studied by a high capacity assay.
Toral-Barza L; Zhang WG; Lamison C; Larocque J; Gibbons J; Yu K
Biochem Biophys Res Commun; 2005 Jun; 332(1):304-10. PubMed ID: 15896331
[TBL] [Abstract][Full Text] [Related]
19. [Troponin T kinase: possible relationship to casein kinases of the G type].
Dobrovol'skiĭ AB; Risnik VV; Gusev NB
Biokhimiia; 1981 Jun; 46(6):1006-14. PubMed ID: 6942895
[TBL] [Abstract][Full Text] [Related]
20. Characterization of protein kinase C theta activation loop autophosphorylation and the kinase domain catalytic mechanism.
Czerwinski R; Aulabaugh A; Greco RM; Olland S; Malakian K; Wolfrom S; Lin L; Kriz R; Stahl M; Huang Y; Liu L; Chaudhary D
Biochemistry; 2005 Jul; 44(28):9563-73. PubMed ID: 16008341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
